Navigation Links
Transcept Pharmaceuticals to Present at Cowen and Company's 27th Annual Health Care Conference in Boston
Date:3/5/2008

PT. RICHMOND, Calif., March 5 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. today announced that Thomas P. Soloway, Senior Vice President & Chief Financial Officer, will present at Cowen and Company's 27th Annual Health Care Conference at the Boston Marriott Copley Place on Thursday, March 20, 2008 at 9:00 AM Eastern Time.

About Transcept Pharmaceuticals

Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company deriving significant new patient benefits from proven CNS drugs. Transcept development projects leverage new understanding of CNS conditions to provide additional uses and enhanced clinical benefits for existing active agents. The lead Transcept product candidate, Intermezzo(R) (zolpidem tartrate lozenge), is a low dose sublingual formulation of zolpidem for the treatment of insomnia in patients who awaken in the middle of the night and have difficulty returning to sleep. Phase 3 clinical trials have been completed for Intermezzo(R) and Transcept plans to submit an NDA in the third quarter of 2008. Another product being developed by Transcept is TO-2060, a novel, fixed-dose combination of olanzapine and ondansetron for the treatment of dopamine associated psychiatric disorders. For further information, please visit the company's website at: http://www.transcept.com.

Contacts:

Transcept Pharmaceuticals, Inc. The Ruth Group

Michael Gill Investors / Media

Director of Communications Stephanie Carrington / Jason Rando

(510) 215-3575 (646) 536-7017 / 7025

mgill@transcept.com scarrington@theruthgroup.com

jrando@theruthgroup.com


'/>"/>
SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Transcept Pharmaceuticals to Present at the Susquehanna Financial Groups SIGnificant Investment Options in Healthcare Conference
2. Transcept Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
3. Transcept Pharmaceuticals to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
4. Transcept Pharmaceuticals to Present at RBC Capital Markets 2007 Healthcare Conference
5. Transcept Pharmaceuticals to Present at 19th Annual Piper Jaffray Health Care Conference
6. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
7. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
8. ISTA Pharmaceuticals Announces Conference Call and Webcast of Fourth Quarter 2007 Financial Results
9. Affinium Pharmaceuticals, Ltd. Announces Initiation of a Phase I Clinical Trial for AFN-1252, its Novel Anti-staphylococcal Antibiotic
10. Indevus Pharmaceuticals Announces Retirement Plans For Its CEO and Chairman
11. MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008).... 21 A prestigious group of physic... gather in Williamsburg, VA on March 27-29, 2009 a...cal information on cutting-edge therapeutic protoc...esearch advances that impact patient care. The ful...n information is available at www.bioconferences....
(Date:11/21/2008)... use is more prevalent and smoking cessation less ...ctivity Disorder (A.D.H.D.) In a study of smokers..., those who exhibited elevated hyperactivity and i...wer quit rates after 8 weeks than those with inatt.... symptoms. The study, now available online in N...
(Date:11/21/2008)...RNewswire/ -- Three Minnesotans who successfully,...ial on-ice presentation at,the Minnesota Wild gam...nners,were participants in The QuitCash Challenge...ota(SM) and QUITPLAN(R) Services. , The gra... two runners-up,will get $1,000 gift cards from G...
(Date:11/21/2008)...RNewswire/ -- In a recent announcement, Governor,...d Use Tax to include,"luxury" items such as veter...,in animal shelter overpopulation. Animal welfar...nd urging all pet owners to take action and contac... tax. , "Our companion animals are family m...
Breaking Medicine News(10 mins):Health News:17th Annual Congress on Women's Health Convenes March 27-29, 2009 in Williamsburg, VA 2Health News:Ability to quit smoking may depend on ADHD symptoms, Columbia researchers find 2Health News:Lucky Quitters to Receive Big Money in Stop-Smoking Contest 2Health News:A Recommended Sales and Use Tax Proposed by Governor Schwarzenegger Will Tax Veterinary Services, Says Social Compassion in Legislation 2Health News:A Recommended Sales and Use Tax Proposed by Governor Schwarzenegger Will Tax Veterinary Services, Says Social Compassion in Legislation 3
...om Columbia University Medical Center have uncover...itch for severe pain. They hope to manufacture dru...imply switching off. // Most prior attempts at al... the "second order" neurons in the spinal cord tha...
...nd Social Welfare’s Health Education Unit (HEU) in...on program for more than 40 communities in the cou...e' attempts to get the people thinking abut HIV AI...rgency Response Council on HIV and AIDS (NERCHA) P...
...gators at St. Jude Children's Research Hospital it...the normal mammary gland function during nursing c...n leukemia only if it undergoes mutation and fuses... normal function of this gene suggests that drugs ...
...der who experience migraines with aura (associated...urbances) are at a higher risk for heart// attack,... cardiovascular disease compared to women who do n...ne without aura, the most common form of migraine,...
Other Medicine News:Health News:It may be possible to switch off acute pain 2Health News:Gene Responsible For Mammary Gland Function, When Mutated Results in Leukemias 2Health News:Gene Responsible For Mammary Gland Function, When Mutated Results in Leukemias 3Health News:Migraines with Aura Associated with Increased Risk for Cardiovascular Disease 2
(Date:11/19/2008)...m Roche- , , MONTVALE, N.J., Nov. 19 /PRNew...Nasdaq: MEMY ) today announced that it has achie...3487/MEM 3454, its lead alpha-7 nicotinic receptor...schizophrenia (CIAS). The Company has randomized ....0 million payment from its partner Roche. Memory...
(Date:11/18/2008)...ire-USNewswire/ -- Forty-two leading U. S. scienti...l forum to consider cutting-edge innovations that ...onomy from outbreaks of dangerous zoonotic disease...ng those innovations: , , , , A...at detects highly contagious and dangerous zoonoti...
(Date:11/13/2008)...al Supplements Prior to Surgery, ARLINGTON HEIGHT...fying,malnutrition before surgery in massive weigh...ficantly decrease surgical complications, accelera...atient energy levels,according to a study in the ...ry(R), the official medical journal of the America...
(Date:11/12/2008)...ael, November 12 Surgeons,at the U...d that,patient-specific CTA data can be converted ...mbionix US) with high face validity. The surgeons,... operative flow,increased patient safety and effi...ive and fluoroscopy time and the amount of contras...
Breaking Medicine Technology:Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Plastic Surgeons Warn of Malnutrition in Body Contouring Patients 2Vascular Surgeons Agree: Case Rehearsal Improves Outcomes 2Effective health messages may yield vaccine compliance among ER workers 22136 1Effective health messages may yield vaccine compliance among ER workers 22136 2Bill Allowing Medical Privacy Intrusion Fails in Sacramento 3B Anti Privacy Bill by Auto Insurers Faces Vote Wednesday 22133 1Bill Allowing Medical Privacy Intrusion Fails in Sacramento 3B Anti Privacy Bill by Auto Insurers Faces Vote Wednesday 22133 2Bill Allowing Medical Privacy Intrusion Fails in Sacramento 3B Anti Privacy Bill by Auto Insurers Faces Vote Wednesday 22133 3AMA Adopts New Policies at Annual Meeting 22128 1AMA Adopts New Policies at Annual Meeting 22128 2Hospital Workers Say Concessions Will Diminish Patient Care 22125 1Hospital Workers Say Concessions Will Diminish Patient Care 22125 2
...)--Mar 15, 2007 - A small clinical,trial of a medi...,conclusive benefit for patients with the impulsiv...he Stanford University,School of Medicine., But th...ications, including the one in the trial, may stil..., More than 1.2 million people in the United State...
...ewswire/ -- Up to two million,Americans are affect...ed. Its primary complication, pulmonary embolism (...han breast cancer and,AIDS combined. , The Coaliti...sponsored an online survey of a nationally represe...rvey, which was conducted by Penn,Schoen & Be...
Other Medicine Technology:Stanford Study Finds No Conclusive Benefit From Treating,Kleptomania With Medication 2DVT Awareness Survey Findings for Respondents in High-Risk Groups:,Obese Individuals 2
...veloped for the World Health Organization as a non... widely used in clinical trials and in the assessm...les are diluted in buffer and the Estrone-3-Glucur...ed immunoassay with magnetic second antibody separ...
The DSL 10-8700 ACTIVE® Estrone Enzyme Immunosorbent Assay (EIA) Kit provides materials for the quantitative measurement of Estrone in serum. The procedure follows the basic principle of enzyme i
Helmer presents the i.Series refrigerator iB245, packed with innovative solutions for the blood bank. With more sophisticated features than ever before, i.Series Blood Bank Refrigerators are at the f
This storage freezer, which is based on our premium freezer line, maintain red cells safely below regulatory standards at -86C (-123F). Recorder is standard for model 8627. Model 8627 is UL Listed, C
Medicine Products: